Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

MMC AND KROLL

Reprints

After several years of ownership, MMC puts Kroll back in the hands of its ex-CEO

JULY 2004: Marsh & McLennan Cos. Inc. acquires Kroll Inc. for approximately $1.9 billion cash.

OCTOBER 2004: Kroll CEO Michael G. Cherkasky replaces Jeffrey W. Greenberg as MMC CEO.

JANUARY 2008: Brian Duperreault replaces Mr. Cherkasky as MMC president and CEO and lists Kroll among underperforming MMC operations he hopes to fix.

MAY 2008: MMC rebuffs Kroll buyout inquiry from London-based B.C. Partners Ltd. Mr. Duperreault announces plans to divest Kroll Government Services Inc. and Kroll Factual Data Corp. and moves Kroll's corporate advisory and restructuring business into a separate unit. MMC takes $540 million in impairment charges in connection with the realignment.

NOVEMBER 2008: Simon V. Freakley, CEO of the realigned corporate advisory and restructuring business, leads a management buyout of the unit's European business in conjunction with a management buyout of the unit's U.S. operations known as Kroll Zolfo Cooper. The companies begin operating as separate partnerships under the name Zolfo Cooper. Also that month, MMC sells U.K.-based restructuring unit Kroll Talbot Hughes to management. The business is renamed Talbot Hughes McKillop L.L.P.

JUNE 2009: MMC sells Kroll Government Services to New York-based private equity firm Veritas Capital for an undisclosed sum. The unit is renamed KeyPoint Government Solutions Inc. MMC takes a $315 million impairment charge in connection with the sale.

FEBRUARY 2010: MMC agrees to sell Kroll Laboratory Specialists to Inverness Medical Innovations Inc. for $110 million in cash.

MARCH 2010: MMC is reported to be accepting bids for the remainder of Kroll's operations, seeking $1.3 billion.

JUNE 2010: MMC announces agreement to sell Kroll to Altegrity Inc.—headed by Mr. Cherkasky—for $1.13 billion.